A comparison of two risk prediction tools used to calculate an individual’s risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition to the short-term, 10-year risk to help inform when to begin medication therapy for stage 1 hypertension, or high blood pressure, according to new research published today in Hypertension, an American Heart Association journal.
Walgreens CEO Rosalind Brewer is leaving the pharmacy giant after 2.5 years
Rosalind Brewer is stepping down from her post as Walgreens CEO after less than three years in the top job, the company said on Friday.